Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: SOBI Receives Positive CHMP Opinion For Tryngolza

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    16/10/2026 11:54
    BRIEF-SOBI Receives Positive CHMP Opinion For Tryngolza
    Oct 16 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:
    • SOBI RECEIVES POSITIVE CHMP OPINION FOR TRYNGOLZA® (OLEZARSEN) FOR THE TREATMENT OF SEVERE HYPERTRIGLYCERIDEMIA (SHTG)
    Source text: https://www.sobi.com/en/press-releases/sobi-receives-positive-chmp-opinion-tryngolzar-olezarsen-treatment-severe-hypertriglyceridemia-shtg-2488430
    Further company coverage: SOBIV.ST

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news